SUBMISSION DEADLINE: December 1, 2025
NOTIFICATION DATE: December 8, 2025
We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:
- Aesthetic Dermatology
- Alopecia
- Blistering Diseases
- Cosmeceuticals
- Fillers and Neuromodulators
- Granulomatous Diseases
- Inflammatory Skin Conditions (Acne, Rosacea, Atopic Dermatitis, Eczema, Psoriasis, Hidradenitis Suppurativa, Seborrheic Dermatitis, etc.)
- Infectious Diseases
- Keloids
- Lasers and Energy-Based Devices
- Nail Disorders
- Pediatric Dermatology
- Pigmentary Disorders (Melasma, Vitiligo, Hyperpigmentation, Hypopigmentation, Photodamage, etc.)
- Skin Cancer
- Surgical Dermatology
- Wound Healing
- Other Dermatologic Topics
At least one (1) author must be registered for the in-person meeting to have their abstracts considered for poster display. All accepted abstracts will be displayed at the ODAC Dermatology Conference, January 16-19 2026, to be held at the Omni ChampionsGate, Orlando, Florida.
In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination, and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets, and any web-enabled device (including desktops), and uses channels such as mobile, email, and push notification to connect with our global community of healthcare providers and researchers.
Download the App:
If you are returning to complete or check the status of your submission, please sign-in (link sign-in to the main sign-in page of the abstract page and then delete this parentheses) using your email address and password.
Encore posters are welcome!
Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts.
At least one (1) author (or representative) must be registered for the in-person meeting to have their abstracts considered for poster display
Abstract Formatting and Content Guidelines
- Language: English
- Authors: full last name, first name, affiliations, degrees and contact information
- Font: Arial
- Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
- Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg
- References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)
- Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
- Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, Discolures and Conclusions
- Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.
Please note that abstracts will not be accepted if the presenting author’s name is not bolded, the presenting author’s email is not included and all authors’ disclosures are not listed.
If you have any questions, please contact MedscapeLIVE! at abstracts@medscapelive.com.